LMH STRATEGIC SOLUTIONS

Lobbying for INCYTE CORPORATION · Biopharmaceutical Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate · $50,000.00 income · posted Jul 5, 2026

Lobbying activity 2

Health Issues

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.

Pharmacy

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.